Introduction and Legal Context Clause Samples

The 'Introduction and Legal Context' clause serves to set the stage for the agreement by outlining its purpose, scope, and the legal framework under which it operates. Typically, this clause identifies the parties involved, references the relevant laws or jurisdictions, and may summarize the intent or background of the contract. By providing this context, the clause ensures that all parties have a clear understanding of the agreement's foundation and the legal environment governing their relationship, thereby reducing ambiguity and potential disputes about interpretation.
Introduction and Legal Context. This document elaborates an agreement of the Core Regulatory Authorities (hereafter: “Core NRAs”), agreed on 9 May 2025 at the Core Energy Regulators’ Regional Forum (hereafter: “CERRF”) on the Core Transmission System Operators’ (hereafter: “Core TSOs”) proposal for the fourth amendment of the Intraday Capacity Calculation Methodology of the Core Capacity Calculation Region (hereafter “Core ID CCM 4th amendment proposal”) in accordance with Article 20ff of the Commission Regulation (EU) 2015/1222 of 24 July 2015 establishing a guideline on capacity allocation and congestion management as modified by Commission Implementing Regulation (EU) 2021/280 of 22 February 2021 amending Regulations (EU) 2015/1222, (EU) 2016/1719, (EU) 2017/2195 and (EU) 2017/1485 in order to align them with Regulation (EU) 2019/943 (hereafter “CACM Regulation”). Pursuant to Article 9(7) of the CACM Regulation, Core TSOs submitted an amended proposal. This proposal was received by the last regulatory authority on 27 March 2025.
Introduction and Legal Context. This service specific information sharing agreement forms a second tier agreement under the overarching Derby and Derbyshire Safeguarding Children Boards’ Information Sharing Agreement. The general principles underpinning the sharing of personal information follow the Data Protection and Caldicott principles on obtaining and using personal information and are detailed in the overarching agreement. The agreement will be reviewed annually and any partner can request changes.
Introduction and Legal Context. 1.1. The Chief Officers and the Policing Bodies wish to enter into a collaboration agreement pursuant to sections 22A to 23I of the Police Act 1996 (as amended by the PRSRA) containing provision relating to: 1.1.1. the discharge of functions of members of a police force (“force collaboration provision”); and/or 1.1.2. the support by a policing body for another policing body (“policing body collaboration provision”); and/or 1.1.3. the support by a policing body for the police force which another policing body is responsible for maintaining (“policing body and force collaboration provision”);
Introduction and Legal Context. This document elaborates an agreement of All Regulatory Authorities, agreed at the Energy Regulators’ Forum on 13 December 2016, on the All TSO proposal for the Common Grid Model Methodology (CGMM) submitted in accordance with Article 17(1) of the Commission Regulation (EU) 2015/1222 of 24 July 2015 establishing a Guideline on Capacity Allocation and Congestion Management (Regulation 2015/1222). This agreement of All Regulatory Authorities shall provide evidence that a decision on the CGMM does not, at this stage, need to be adopted by ACER pursuant to Article 9(11) of the Regulation 2015/1222. This agreement is intended to constitute the basis on which All Regulatory Authorities will each subsequently request an amendment to the CGMM proposal pursuant Article 9(12). The legal provisions relevant to the submission and approval of the CGMM proposal and this All Regulatory Authority agreement on the CGMM proposal, can be found in Articles 3, 9, 17, 18 and 19 of the Regulation 2015/1222.
Introduction and Legal Context. This document describes the views of Core National Regulatory Authorities (hereafter “Core NRAs”) on a working, Regional Coordination Committee (hereafter “RCC”) level on the second amendment of the fallback procedures (hereafter “second amendment of the Core fallback procedures), including Shadow Allocation Rules (hereafter “SAR”), by the Core Transmission System Operators’ (hereafter “Core TSOs”) in accordance with Article 44 of the Commission Regulation (EU) 2015/1222 of 24 July 2015 establishing a guideline on capacity allocation and congestion management as modified by Commission Implementing Regulation (EU) 2021/280 of 22 February 2021 (hereafter “CACM Regulation”). All Core TSOs submitted the second amendment of the Core fallback procedures and SAR in accordance with Article 9(7) of the CACM Regulation to NRAs until 8 March.
Introduction and Legal Context. ‌ 1.1. The Parties entered into a collaboration agreement pursuant to section 22A of the Police Act 1996 dated December 2019 pursuant to which they established a collaborative venture known as Modern Slavery Police Transformation Programme (now the Modern Slavery and Organised Immigration Crime Programme) (the “Programme”) with the aim of providing support to police forces in England and Wales to improve their response to Modern Slavery through the establishment of the Modern Slavery Teams (as defined in that agreement) (the “2019 Collaboration Agreement”). The 2019 Collaboration Agreement was amended by further Agreements dated 2020 and 2021.‌ 1.2. The 2019 Collaboration Agreement stated that the Strategic Oversight Board shall be entitled to recommend that the Programme shall continue beyond 31st March 2020 provided that the terms of the agreement under Section 22A of the Police Act 1996 (as amended) to continue the Programme beyond 31st March 2023 are the terms set out in the APACCE Agreement. 1.3. It is acknowledged that there was no formal agreement for the 2022/2023 period, however the services of the Programme continued to be provided in line with the 2021/2022 agreement. There are no known Liabilities that arouse during 2022/2023 period. 1.4. Accordingly, the Parties entered into a collaboration agreement pursuant to section 22A of the Police Act 1996 on the terms set out in the APACCE Agreement dated April 2022 confirming the extension of the Programme during the period from 1st April 2023 to 31st March 2024 (the “2023 Collaboration Agreement”).‌ 1.5. The Chief Officers, Policing Bodies and other Parties now wish to confirm the extension of the Programme during the period 1st April 2023 to 31st March 2024 and accordingly wish to enter into a collaboration agreement (again on the terms set out in the APACCE Agreement) pursuant to section 22A of the Police Act 1996 (as amended by the PRSRA) containing provision relating to the discharge of functions of members of a police force (“force collaboration provision”). 1.6. This Agreement sets out the arrangements for the discharge of the Policing Bodies’ functions under this collaboration. 1.7. The Parties are cognisant of their rights and responsibilities under the PRSRA and that Policing Bodies are constrained by the provisions of section 18 of the PRSRA and as a result unable to delegate their functions to Chief Officers, other Policing Bodies, police constables or staff of either Chief Officers or other...
Introduction and Legal Context. This protocol applies to the relevant signatories in partnership with SEPT.

Related to Introduction and Legal Context

  • Introduction and Purpose 1.1 This annex is designed to provide customers of the London Metal Exchange (LME) with an overview of the structure of the LME, market terminology, and order execution. It is not a comprehensive trading guide, nor a complete guide to market terminology. Customers should always ensure that their requirements are explained in detail to the member responsible for order execution.

  • Introduction and definitions 1.1 This agreement (the “Grant Agreement”) consists of 23 Clauses, 2 Schedules and 2

  • Introduction and Background The purpose of this Schedule 2 (Contract Services and Contract Supplies) is to set out the characteristics of the Contract Services and/or Contract Supplies (as the case may be) and Funding that the Provider will be required to make available to all Contracting Authorities in relation to Lot 1 and/or Lot 2 (as the case may be) and to provide a description of what the Contract Services and/or Contract Supplies (as the case may be) and Funding will entail.

  • Formation and Purpose In order to oversee, review and coordinate the activities of the Parties under this Agreement, Pfenex and Hospira will form an executive steering committee promptly after the Signature Date (the “Executive Steering Committee”), whose initial members are listed in that certain memorandum exchanged between the Parties on the Signature Date and referencing this Agreement. The Executive Steering Committee shall, in accordance with the procedures set forth in Section 7.4, (a) review and comment on the development, manufacture and commercialization of Product, including the Development Plan, the Technical Transfer Plan, and any clinical protocols for the conduct of the Comparative Clinical Study, (b) consult with Hospira regarding Hospira’s plan for seeking Regulatory Approval, (c) review and approve any modifications or amendments to the Development Plan, (d) review and approve the clinical protocols for the conduct of the Comparative Clinical Study and any modifications or amendments thereto, (e) review and approve the Technical Transfer Plan and any modifications or amendments thereto, (f) review and comment on the IP Strategy and any modifications or amendments thereto, (g) serve as a forum for discussion for matters relating to the development, manufacture and commercialization of Product, (h) establish an estimated budget for Regulatory Approval Costs to be paid by Hospira for each calendar year by October 31st of the prior calendar year, (i) establish one or more working committees, which shall include a product development working committee, a manufacturing working committee and other working groups, committees and subcommittees as may be established by mutual consent of Pfenex and Hospira (each, a “Working Committee”), and (j) performing such other duties as are specifically assigned to the Executive Steering Committee in this Agreement. The Executive Steering Committee shall be the primary forum for Pfenex and Hospira to communicate with one another regarding the plans for, and progress of, the development and commercialization of Product as well as any associated problems. [***] Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions.